Analyst consensus rating
Carlsmed Analyst Rating: Strong Buy
CARL is rated Strong Buy by 5 analysts with a $19.20 target. As of 2026-09-02.
Direct answer
Carlsmed's consensus rating is Strong Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $19.20.
Forecast evidence checked September 2, 2026.
Get free Carlsmed email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $16.64
- Average price target
- $19.20
- High price target
- $23.00
- Low price target
- $17.00
- Low target gap
- +2.2%
- Target upside
- +15.4%
- High target gap
- +38.2%
- Target range width
- 36.1%
- Consensus rating
- Strong Buy
- Analysts
- 5
- Evidence date
- September 2, 2026
- Valid through
- September 9, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Carlsmed?
Carlsmed has a verified Strong Buy consensus. The same dataset has an average price target of $19.20.
How far are Carlsmed's low and high targets from the recorded price?
The low target implies +2.2%, while the high target implies +38.2%.
How many analysts are included in Carlsmed's consensus?
The verified consensus includes 5 analysts.
How is Carlsmed's target upside or downside calculated?
The average target of $19.20 is divided by the recorded price of $16.64, then one is subtracted to produce +15.4%. This does not guarantee a future return.
When was Carlsmed's analyst forecast verified?
The data was verified on 2026-09-02. The dataset is valid through 2026-09-09.